Global Thrombectomy Devices Market

Thrombectomy Devices Market size is expected to grow at 6.6% throughout the forecast period, reaching nearly USD 2.73 in 2032.

To know about the Research Methodology :- Request Free Sample Report

Global Thrombectomy Devices Market Dynamics:

Thrombectomy is interventional surgery to remove blood clot from inside an artery and vein. Rising preference for minimally invasive surgeries is increasing the demand for thrombectomy devices.

The rising number of surgical techniques, increasing senior population, and the growing excellence of suturing material are boosting the growth of the global thrombectomy devices market. Constant technological innovations, growing healthcare expenses across emerging markets, and wide application of ultrasound in vascular treatment provide key growth opportunities for the global thrombectomy devices market during the forecast period. Lack of trained specialists and complex use of thrombectomy devices, as well as less awareness about thrombectomy, are limiting the growth of the thrombectomy devices market.

The peripheral vascular applications segment is estimated to hold the highest CAGR during the forecast period owing to the favorable reimbursement policies executed by various governments on peripheral procedures.

A rising number of surgeries performed with image-guided, the existence of favorable reimbursement for thrombectomy procedures, technical advancement in minimally invasive surgical methods, and increasing need for miniaturized therapeutic devices is driving the demand for ambulatory surgical centers during the forecast period.

Global Thrombectomy Devices Market Segment Analysis:

By Product Type

Based on Product Type, the Mechanical Thrombectomy Devices segment dominated the Global Thrombectomy Devices Market in 2025 and is expected to maintain its dominance during the forecast period. The dominance of this segment is attributed to the increasing adoption of minimally invasive procedures and the high efficiency of mechanical devices in removing blood clots, particularly in acute ischemic stroke treatment. Technological advancements in stent retrievers and clot retrieval systems are further supporting the growth of this segment.

By Application

Based on Application, the Cardiovascular segment held the largest market share in 2025. The growth of this segment is mainly driven by the rising prevalence of cardiovascular diseases such as coronary artery disease, pulmonary embolism, and deep vein thrombosis. Increasing awareness regarding early diagnosis and treatment of vascular disorders is also contributing to the growth of this segment.

By End User

Based on End User, the Hospitals segment dominated the Global Thrombectomy Devices Market in 2025. Hospitals remain the primary treatment centers for thrombectomy procedures due to the availability of advanced medical infrastructure, specialized healthcare professionals, and emergency stroke care facilities. The increasing number of specialized stroke centers and vascular treatment units is further supporting the growth of this segment.

Global Thrombectomy Devices Market Regional Analysis:

The Global Thrombectomy Devices Market is witnessing significant growth due to the increasing prevalence of cardiovascular and neurovascular diseases, rising adoption of minimally invasive procedures, and growing awareness regarding early diagnosis and treatment of vascular disorders. Favorable reimbursement policies, particularly in the United States, along with a rising number of clinical trials and technological advancements in thrombectomy devices, are further supporting market expansion. North America dominated the market in 2025, followed by Europe, owing to advanced healthcare infrastructure, strong presence of leading medical device manufacturers, and high adoption of innovative treatment technologies.

Global Thrombectomy Devices Market – Key Highlights

• Market analysis and forecast of the Global Thrombectomy Devices Market in terms of value for the period 2026–2032.

• Detailed analysis of market drivers, restraints, opportunities, and challenges influencing market growth.

• Comprehensive study including PESTEL analysis, Porter’s Five Forces analysis, and SWOT analysis.

• Market segmentation based on product type, application, end user, and region.

• Regional market analysis for North America, Europe, Asia Pacific, South America, and the Middle East & Africa, along with country-level insights.

• Profiles of major industry players, including their market positioning, strategic initiatives, and core competencies.

• Assessment of competitive developments such as mergers, acquisitions, partnerships, investments, and product launches in the market.

Recent Industry Developments (2025–2026)

The Scope of Global Thrombectomy Devices Market: Inquire before buying

Global Thrombectomy Devices Market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
South America (Brazil, Argentina Rest of South America)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)

Global Thrombectomy Devices Market Key Players

1. Stryker Corporation
2. Medtronic plc
3. Boston Scientific Corporation
4. Johnson & Johnson (Cerenovus)
5. Terumo Corporation
6. Penumbra, Inc.
7. Teleflex Incorporated
8. Abbott Laboratories
9. AngioDynamics, Inc.
10. Argon Medical Devices, Inc.
11. Edwards Lifesciences Corporation
12. Merit Medical Systems, Inc.
13. Koninklijke Philips N.V.
14. Becton, Dickinson and Company (BD)
15. Cook Medical LLC
16. Inari Medical, Inc.
17. MicroPort Scientific Corporation
18. Asahi Intecc Co., Ltd.
19. phenox GmbH
20. Acandis GmbH & Co. KG
21. Rapid Medical
22. Imperative Care Inc.
23. Vesalio LLC
24. Thrombolex, Inc.
25. Mermaid Medical